Investigating drug-induced urinary retention: a pharmacovigilance analysis of FDA adverse event reports from 2004 to 2024
This study underscores the importance of pharmacovigilance in identifying and understanding DIUR. Further research is needed to confirm these findings and develop strategies to manage and reduce the risk, improving patient outcomes.
Authors
- Fu‐Chun Zheng (ORCID: https://orcid.org/0000-0003-3184-3054)
- Sheng Li (ORCID: https://orcid.org/0000-0001-8080-9712)
- Zhipeng Wang (ORCID: https://orcid.org/0000-0002-1145-234X)
- Bin Fu (ORCID: https://orcid.org/0000-0001-6686-7561)
- Wei Liu
- Yuyang Yuan
- Fei Wang (ORCID: https://orcid.org/0000-0001-9459-9461)
Institutions
- Nanchang University (CN)
Publication Details
- Journal
- Expert Opinion on Drug Safety
- Published
- 2024-09-14
- DOI
- https://doi.org/10.1080/14740338.2024.2405126
- Citations
- 1
- Primary Topic
- Urinary Bladder and Prostate Research
- Type
- article
- Field-Weighted Citation Impact
- 0.54